AMNEAL PHARMACEUTICALS, INC. Earnings Per Share (Diluted)
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Earnings Per Share (Diluted) of $0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.18, a 157.14% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.19, a 375.00% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.01.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2025-06-30 was $0.07, a 250.00% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2025 was $0.22.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2024 was -$0.38.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2023 was -$0.48.
- AMNEAL PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2022 was -$0.86, a 1328.57% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.18 10-Q · filed 2026-08-06 | $0.37 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $0.19 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $0.22 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-06 | $0.08 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.11 10-Q · filed 2025-11-06 | $0.02 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | $0.07 10-Q · filed 2026-08-06 | $0.11 10-Q · filed 2026-08-06 | $0.01 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.01 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | $0.04 10-Q · filed 2026-05-07 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.38 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.02 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.28 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.02 10-Q · filed 2025-08-07 | -$0.28 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.30 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | -$0.48 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $0.06 10-Q · filed 2024-11-12 | $0.09 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.08 10-Q · filed 2024-08-09 | $0.03 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$0.05 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$0.86 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$0.02 10-Q · filed 2023-11-09 | -$0.83 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.80 10-Q · filed 2023-08-08 | -$0.82 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.01 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.07 10-K · filed 2024-03-14 | |||
| 2021-09-30 | -$0.03 10-Q · filed 2022-11-07 | $0.11 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $0.10 10-Q · filed 2022-08-08 | $0.14 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.04 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.61 10-K · filed 2023-03-03 | |||
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-08 | $0.63 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$0.08 10-Q · filed 2021-08-09 | $0.69 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.78 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$0.23 10-K · filed 2020-03-02 | -$2.74 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$2.03 10-Q · filed 2020-11-06 | -$2.56 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | -$0.13 10-Q · filed 2020-08-06 | -$0.51 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$0.37 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$0.07 10-K · filed 2020-03-02 | -$0.16 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $0.05 10-K · filed 2020-03-02 | -$0.10 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$0.15 10-K · filed 2020-03-02 | |||
| 2018-03-31 | $0.00 10-K · filed 2020-03-02 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 | |||
| 2017-09-30 | $0.00 10-K · filed 2019-03-01 | |||
| 2017-06-30 | $0.00 10-K · filed 2019-03-01 | |||
| 2017-03-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |